Phio Pharmaceuticals (PHIO) EBITDA Margin Growth (1y) (2013 - 2019)
Phio Pharmaceuticals (PHIO) EBITDA Margin Growth (1y) (2013 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | -1,651.00 |
| 10 | Phio Pharmaceuticals | 13.65 Mn | 13.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -48,427.00 |
| Mar 31, 2016 | -1.38 Mn |
| Mar 31, 2015 | -76,815.00 |
| Dec 31, 2014 | -778,867.00 |
| Sep 30, 2014 | -1.16 Mn |
| Jun 30, 2014 | -1.60 Mn |
| Mar 31, 2014 | 1.93 Mn |
| Dec 31, 2013 | -440,276.00 |
| Sep 30, 2013 | 72,435.00 |